Research output per year
Research output per year
Personal profile
Research interests
- Leukemia
- Hematology malignancy
- miRNA
- lncRNA
- transcription regulation
- drug resistance
- targeted therapy
- precision medicine
Fingerprint
Dive into the research topics where Tianxiang Hu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
RHOA-regulated IGFBP2 promotes invasion and drives progression of BCR-ABL1 chronic myeloid leukemia
Zhang, H., Cai, B., Liu, Y., Chong, Y., Matsunaga, A., Mori, S. F., Fang, X., Kitamura, E., Chang, C. S., Wang, P., Cowell, J. K. & Hu, T., Jan 2023, In: Haematologica. 108, 1, p. 122-134 13 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
AML-060 A Truncated Nucleus Isoform of FGFR1 Drives the Transformation of Leukemia Stem Cells in Leukemogenesis
Cai, B., Liu, Y., Chong, Y., Zhang, H., Mori, S., Matsunaga, A., Fang, X., Cowell, J. & Hu, T., Oct 2022, In: Clinical Lymphoma, Myeloma and Leukemia. 22, p. S210Research output: Contribution to journal › Article › peer-review
-
A truncated derivative of FGFR1 kinase cooperates with FLT3 and KIT to transform hematopoietic stem cells in syndromic and de novo AML
Cai, B., Liu, Y., Chong, Y., Mori, S. F., Matsunaga, A., Zhang, H., Fang, X., Chang, C. S., Cowell, J. K. & Hu, T., Dec 2022, In: Molecular cancer. 21, 1, 156.Research output: Contribution to journal › Article › peer-review
Open Access -
IRAK1-regulated IFN-γ signaling induces MDSC to facilitate immune evasion in FGFR1-driven hematological malignancies
Cai, B., Liu, Y., Chong, Y., Zhang, H., Matsunaga, A., Fang, X., Pacholczyk, R., Zhou, G., Cowell, J. K. & Hu, T., Dec 2021, In: Molecular cancer. 20, 1, 165.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Mechanisms of resistance to FGFR1 inhibitors in FGFR1-driven leukemias and lymphomas: Implications for optimized treatment
Cowell, J. K. & Hu, T., 2021, In: Cancer Drug Resistance. 4, 3, p. 607-619 13 p.Research output: Contribution to journal › Review article › peer-review
Open Access2 Scopus citations